News PageRareCyte RareCyte® selected for the Wellcome Leap In Utero program RareCyte Inc., ("RareCyte" or "The Company") a leading provider of Precision Biology products and services…Arboretum_JDNovember 16, 2022
Home PageNews PageRareCyte RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company developing and manufacturing proprietary platforms…Arboretum_JDSeptember 9, 2021